Registry for understanding Scleroderma at the Hospital for Special Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to enhance the understanding of Scleroderma, a complex rheumatic disease, by collecting clinical data and biological samples from patients. Participants will complete health questionnaires and may donate blood for research purposes, which is encouraged but optional. The registry will facilitate ongoing research into the clinical features, genetics, and pathobiology of Scleroderma, ultimately aiming to improve treatment options for this currently untreatable condition. Patients will also receive a thorough medical evaluation and guidance on treatment options from specialized physicians.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals older than 18 years of age with Scleroderma

Exclusion Criteria:

* Individuals younger than 18 years of age
* Individuals older than 18 years of age without Scleroderma

Where it's running

• Hospital for Special Surgery
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Robert F Spiera, MD — Hospital for Special Surgery, New York
• Study coordinator: Eliza Pelrine, BA
• Email: pelrinee@hss.edu
• Phone: (212)774-2123

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• First-in-human test of PRO-203 in healthy adults and people with systemic sclerosis

  Researchers will test a single subcutaneous dose of PRO-203 in healthy adults and in people with systemic sclerosis to see if it is safe and how the body handles it.

  Recruiting at 12 sites Phase 1/2 Prolium Bioscience, Inc · Melbourne, Victoria and 12 other locations · NCT07641634

• EVM18001 for adults with refractory lupus, myasthenia gravis, and scleroderma

  This single-arm study will test an experimental CAR‑T therapy called EVM18001 to see if it is safe and helps adults whose lupus, myasthenia gravis, or scleroderma did not respond to standard treatments.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07470151

• Biopsychosocial (BETY) exercise program for children and adults with scleroderma

  This project will test whether BETY, a biopsychosocial exercise program, helps children and adults with scleroderma improve physical function and psychosocial well-being.

  Recruiting Hacettepe University · Ankara, Altındağ · NCT07292961

• Transcriptomic analysis of skin fibroblasts in scleroderma

  This project will analyze gene activity in skin fibroblasts from people with systemic scleroderma and from surgical controls to see if fibroblasts contribute to the disease.

  Recruiting Centre Hospitalier Universitaire Dijon · Dijon · NCT07256418

• Physical performance and daily function in people with scleroderma

  This project will test which questionnaires and simple physical tests best measure physical performance and daily functioning in children and adults with scleroderma.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07183072

• Chewing and swallowing performance in people with scleroderma

  This project will see how children and adults with scleroderma chew and swallow and collect biopsychosocial information using questionnaires.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07182981

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.